What Happens If You Get Someone Else’s Blood in Your Body?

In most cases, receiving someone else’s blood is uneventful and lifesaving. Millions of transfusions happen every year, and the vast majority go smoothly because the donated blood has been carefully typed, screened, and matched. But when something goes wrong, or when mismatched blood enters your circulation, the consequences range from a mild fever to organ failure and death. Your immune system treats foreign blood much the way it treats any invader: it identifies what does not belong and mounts a defense. The intensity of that defense depends on exactly how “foreign” the blood is and how your body is equipped to respond.

When the Blood Types Do Not Match

The most dangerous scenario is receiving red blood cells that carry the wrong surface markers. Your immune system has preformed antibodies against blood-type antigens you lack. If you are type O and receive type B red blood cells, your anti-B antibodies bind to the B antigens on the donor cells almost immediately, triggering a cascade of complement activation that causes widespread inflammation, a drop in blood pressure, fever, and the destruction of the transfused red blood cells inside your blood vessels. The hemoglobin spilling out of those ruptured cells can damage the kidneys and trigger abnormal clotting throughout the body.

This kind of acute hemolytic reaction can begin after as little as a few milliliters of incompatible blood enter the body.

Symptoms typically hit fast. Patients report a burning sensation at the IV site, chest pain, back pain, and a feeling of impending doom. Blood pressure drops. Urine may turn dark or stop flowing as the kidneys struggle with the flood of free hemoglobin. Left untreated, the reaction can progress to shock, kidney failure, and death. Fortunately, ABO-mismatch transfusions are rare in modern hospitals because of redundant checking systems, but clerical errors still account for the vast majority of cases when they do occur.

The Rh Factor and Delayed Sensitization

Not every mismatch causes an immediate catastrophe. The Rh system works differently from ABO. If you are Rh-negative and receive Rh-positive blood for the first time, you probably will not feel a thing during that transfusion. But your immune system takes notes. More than half of Rh-negative people who receive Rh-positive blood develop antibodies against the Rh(D) antigen afterward.¹ Those antibodies lie in wait. If the same person ever receives Rh-positive blood again, their primed immune system attacks the donor cells much more aggressively, producing a delayed hemolytic reaction that can destroy red cells days or weeks later.

This sensitization is especially consequential for women who may become pregnant. When a Rh-negative mother carries a Rh-positive baby, her antibodies can cross the placenta and attack the fetus’s red blood cells, a condition known as hemolytic disease of the fetus and newborn. Roughly six in every thousand pregnancies are affected by maternal red blood cell antibodies.² This is why blood banks are meticulous about Rh matching, and why Rh-negative pregnant women receive a preventive injection of Rh immune globulin.

Reactions That Have Nothing to Do With Blood Type

Even when the blood is perfectly typed and matched, your body can still protest. The most common transfusion reaction is febrile non-hemolytic transfusion reaction, which is a fancy name for developing a fever and chills without any actual destruction of red blood cells. This happens because stored blood products accumulate immune signaling molecules called cytokines, released by white blood cells sitting in the bag during storage. When those cytokines enter your bloodstream, they act on the brain’s temperature-regulation center and push your set-point temperature upward, producing a fever.³ Platelet products are particularly prone to this because they are stored at room temperature, giving white blood cells more time to churn out cytokines.⁴

These reactions are uncomfortable but rarely dangerous. Removing the leftover plasma from platelet units before transfusion significantly reduces both the frequency and severity of febrile episodes.⁴ Modern blood banks also use leukoreduction filters, which strip out most white blood cells before the product ever reaches the patient, cutting down on cytokine buildup in the first place.

Allergic Reactions and Anaphylaxis

Some people develop hives, itching, or mild allergic symptoms during a transfusion, usually because their immune system reacts to proteins dissolved in the donor plasma. These reactions are typically managed by pausing the transfusion and giving an antihistamine. The more alarming version is full-blown anaphylaxis, which is rare but can be life-threatening. A well-known trigger involves people who are completely deficient in immunoglobulin A, a type of antibody found in plasma. These individuals sometimes develop IgG antibodies that target the IgA in donated blood, and the resulting immune complex activates complement and causes a severe systemic reaction.⁵ Patients known to be IgA-deficient with anti-IgA antibodies receive specially washed blood products to remove the offending plasma proteins.

When Your Lungs Bear the Brunt

Two serious lung complications can follow a transfusion, and they look similar at the bedside but arise from completely different mechanisms.

Transfusion-related acute lung injury, or TRALI, is driven by antibodies in the donor’s plasma that target the recipient’s white blood cells. Those activated white blood cells, primarily neutrophils, rush to the lung’s tiny blood vessels, generate bursts of reactive oxygen, and damage the lining of the capillaries. The result is fluid leaking into the lungs, causing sudden breathing difficulty that resembles a severe pneumonia.⁶ TRALI typically appears within six hours of transfusion and can be fatal, though many patients recover with supportive care.

Transfusion-associated circulatory overload, or TACO, looks similar on a chest X-ray but is essentially a volume problem. If you pump fluid into someone whose heart or kidneys cannot keep up, the excess fluid backs up into the lungs. Patients with pre-existing heart or kidney problems and those with a positive fluid balance are most vulnerable. Interestingly, factors beyond simple volume overload also contribute. Biologically active substances in the transfused product and inflammatory mediators play a role that researchers are still working to fully understand.⁷

Donor Cells That Turn Against You

One of the rarest but most lethal transfusion complications is transfusion-associated graft-versus-host disease. In a normal transfusion, any donor white blood cells that tag along are quickly mopped up by the recipient’s immune system. But if the recipient’s immune system is severely weakened, or if the donor happens to share enough genetic markers with the recipient that the recipient’s immune system does not recognize the donor cells as foreign, those donor T-cells can engraft, multiply, and begin attacking the recipient’s own tissues. Symptoms appear two to thirty days later and include fever, skin rash, jaundice, diarrhea, and a catastrophic drop in blood cell counts as the donor’s immune cells destroy the recipient’s bone marrow.⁸

The mortality rate for this condition is extremely high. Prevention is the only reliable strategy: blood products destined for at-risk patients are irradiated to destroy any viable donor T-cells before they can cause harm. Patients undergoing chemotherapy, organ transplant recipients, and those receiving blood from close relatives are among the groups who need irradiated products.

Infection Risks in the Modern Blood Supply

Before the era of routine screening, transfusion was a meaningful route for transmitting hepatitis and HIV. Today’s blood supply is remarkably safe, with multiple layers of testing, but no screening system catches every infected donation during the “window period,” the brief time after a donor is infected but before tests can detect the pathogen. In one study from a region with relatively high infection rates, the estimated chance of a single donation carrying undetected HIV was roughly one in 26,000, while undetected hepatitis B was about one in 11,000 and hepatitis C about one in 19,000.⁹ In low-prevalence countries with nucleic acid testing, those numbers are far smaller, sometimes vanishingly so. The risk is not zero, but it is low enough that transfusion is overwhelmingly safe compared to the alternative of not transfusing when blood is needed.

Bacterial contamination is a separate concern, particularly for platelet products. Platelets are stored at room temperature to keep them functional, and that warmth also provides a comfortable home for bacteria. Despite advances in screening with automated culture systems, contaminated platelets remain a leading infectious cause of transfusion-related death.¹⁰ Gram-positive skin bacteria are the most frequent culprits, often introduced during the blood draw if skin antisepsis was not thorough.¹¹ Blood banks have responded with pathogen-reduction technologies, improved skin prep protocols, and newer-generation culture detection systems.¹²

What Happens to Stored Blood Inside You

Even perfectly matched, infection-free blood undergoes changes during storage that affect how it performs once it enters your body. Red blood cells stored at refrigerator temperature gradually lose energy molecules and the compound that helps them release oxygen to tissues. Their membranes stiffen and accumulate oxidative damage. As a result, a significant fraction of stored red cells, potentially up to a quarter, are rapidly cleared from the recipient’s circulation within the first 24 hours after transfusion rather than surviving their normal lifespan. The iron released by those destroyed cells and the inflammatory signals they generate may modulate the recipient’s immune system in subtle ways that researchers are still cataloging.

For most patients receiving a few units, this “storage lesion” is clinically manageable. The remaining cells do their job of carrying oxygen. But in massive transfusion scenarios, where a patient’s entire blood volume is replaced within hours due to trauma or surgical hemorrhage, the cumulative effects add up. Massive transfusion carries its own set of metabolic risks: packed red blood cells contain no clotting factors or platelets, so giving many units without also replenishing those components causes dilutional coagulopathy, where the blood loses its ability to clot effectively. Hypothermia from large volumes of cold stored blood, elevated potassium from leaking red cells, and low calcium from the citrate anticoagulant used in storage bags all become urgent problems that trauma teams must manage simultaneously.

Donor Cells That Quietly Move In

Here is something that surprises most people: after a transfusion, a small number of the donor’s white blood cells can survive in your body for months or even years. This phenomenon, called transfusion-associated microchimerism, means that you become, in a tiny way, a genetic mosaic. In a study of female trauma patients who received blood from male donors, seven out of ten showed detectable male donor white blood cells, including multiple cell types, persisting for six months to a year and a half after their transfusion.¹³ The likely explanation is that donor stem cells engraft in the recipient’s bone marrow and establish a kind of mutual tolerance with the recipient’s own immune cells.

Microchimerism has also been detected in other populations. Studies of both older Australian adults and Australian pediatric patients have found evidence of donor white blood cell survival after transfusion, though at varying rates.¹⁴¹⁵ Whether this low-level chimerism has any long-term health consequences remains an open question. It does not appear to cause graft-versus-host disease in these cases, because the number of surviving donor cells is far too small to mount an immune attack. But researchers wonder whether it might subtly influence immune function, autoimmunity, or transplant tolerance over time. For now, it is a biological curiosity rather than a clinical problem.

Accidental Exposure Outside the Hospital

Not all contact with someone else’s blood happens through a transfusion bag. Healthcare workers face occupational exposure through needlestick injuries and blood splashes, and accidents happen outside medical settings as well. The primary concern with accidental blood exposure is the transmission of bloodborne pathogens, principally HIV, hepatitis B, and hepatitis C.

The risk from a single needlestick injury varies by pathogen. Hepatitis B carries the highest transmission risk per exposure event; HIV is considerably lower. What matters most is how quickly the exposed person gets evaluated and, if indicated, starts post-exposure prophylaxis. In a survey of healthcare workers in Botswana, only about a third of those who experienced a sharps injury or blood splash actually reported the exposure, and of those who reported it, roughly seven in ten received prophylactic medication. Of that group, about seven in ten completed the full course.¹⁶ The drop-off at each step is sobering and highlights that the biggest failure point is not the availability of treatment but whether exposed individuals seek it promptly.¹⁷

If you are ever exposed to another person’s blood through a cut, needlestick, or mucous membrane splash, the standard advice is to wash the area thoroughly, report the exposure, and get medical evaluation the same day. Time-sensitive medications can dramatically reduce the chance of infection if started early.

Animal Blood and the Human Body

The question of what happens when non-human blood enters a person is not purely hypothetical. Historically, doctors attempted transfusions from lambs and calves to humans, with predictably poor results. The modern equivalent is the challenge facing xenotransplantation researchers, who study whether pig organs or cells can function in humans. The obstacle is a sugar molecule on pig cells called galactose-alpha-1,3-galactose (commonly shortened to alpha-gal). Humans naturally produce antibodies against this sugar, and when those antibodies encounter pig cells, they trigger a devastating immune response. In pig-to-primate transplants, hyperacute rejection of vascularized organs occurs within ten to sixty minutes as the recipient’s natural antibodies bind to alpha-gal on the donor tissue, activate complement, and cause the blood vessels to clot shut and hemorrhage.¹⁸

This is why you cannot simply substitute animal blood for human blood in an emergency, no matter the circumstances. The immune reaction is so swift and violent that it would likely kill the recipient faster than the blood loss would. Researchers have been working on genetically engineering pigs to remove the alpha-gal sugar from their cells, which is the same line of science that recently enabled the first experimental pig-heart transplants in humans. Those transplants remain experimental and fraught with complications, but the genetics are getting closer to producing pig tissues that the human immune system does not immediately destroy.

Why Blood Donation Matching Goes Beyond A, B, and O

Most people think of blood matching as picking the right letter from A, B, AB, or O, plus positive or negative for Rh. In reality, there are hundreds of known red blood cell antigens grouped into more than 40 blood group systems. For a typical emergency transfusion, matching ABO and Rh is sufficient. But for patients who receive many transfusions over their lifetime, such as those with sickle cell disease or thalassemia, exposure to all those minor antigens adds up. Each mismatch is another opportunity for the immune system to form antibodies, making future transfusions increasingly difficult to match safely. These patients eventually need blood that is matched across many more antigen systems, which is one reason blood banks actively recruit donors from diverse ethnic backgrounds: antigen profiles vary across populations, and the best match for a patient is often someone with a similar genetic heritage.

Finding compatible blood for a heavily alloimmunized patient can take days of laboratory work and coordination between blood banks across a region. It is one of the quieter logistical challenges in transfusion medicine, rarely making headlines but constantly shaping how blood banks operate and whom they recruit.